Verity Ahern

Clinical Associate Professor Verity Ahern is affiliated with the University of Sydney's Westmead Clinical School, Department of Medicine. Her research focuses on radiation oncology, pediatric oncology, and cancer treatment innovations, particularly in proton therapy and carbon ion radiation therapy. She has contributed to international studies on radiation therapy protocols for brain tumors, breast cancer, and pediatric malignancies. Key areas of expertise include radiation dosimetry, clinical quality assurance, and optimizing treatment outcomes while minimizing toxicity. Dr. Ahern has co-authored over 100 peer-reviewed publications and actively participates in global initiatives to advance particle therapy access in Australia.

Her recent work includes evaluating proton therapy's impact on pediatric hearing preservation and analyzing eligibility criteria for carbon ion therapy. She also leads efforts to establish national standards for brachytherapy and particle therapy registries. Dr. Ahern's research emphasizes translating advanced radiation physics into clinical practice, with a focus on precision oncology and genomic assay applications in treatment decisions.

Professional contributions include chairing international pediatric radiation oncology committees and collaborating with the Children's Oncology Group. Her grants include funding for cutting-edge imaging technologies at the Westmead Health Precinct. Dr. Ahern's work bridges clinical care, research, and healthcare policy to improve cancer outcomes across diverse patient populations.